More Articles


Building capacity in digital

Katie Osborne, (Feb 22, 2021)

The new era of digital-first engagement demands new approaches to scaling by harnessing technology, seeing content creation as collaborative and cultivating a startup culture
Access and Evidence

Bringing innovation to rare disease patients in Europe

Izzy Gladstone, (Feb 17, 2021)

Johanna Friedl-Naderer, President, Europe, Canada & Partner Markets, Biogen on how collaboration between governments and industry can lead to better patient outcomes.
Access and Evidence

#Icare4Rare campaign launches to raise awareness ahead of Rare Disease Week 2021

Izzy Gladstone, (Feb 11, 2021)

To help raise awareness of rare disease, Reuters Events, Biogen and EU40 have collaborated to launch the #Icare4rare campaign to give prominence to Rare Disease Week 2021

Trial site management in the post pandemic era

Lucy Fulford, (Jan 26, 2021)

The impacts of 2020 on trials are causing pharma to consider a new direction for trial sites, taking them closer to the patient
Patients and Medical

Better research through patient insights

Andrew Stone, (Jan 26, 2021)

AstraZeneca’s innovations in chronic kidney disease are pointing the way to new ways of involving patients and RWE to drive new insights and better outcomes

Broadening participation in clinical trials: A win for all

Joseph Constance, (Jan 6, 2021)

Broader and deeper outreach, along with RWE, are some of the methods pharma is using to widen trials participation

Blended and augmented: Reimagining the role of the rep

Andrew Stone, (Dec 18, 2020)

The events of 2020 have compelled pharma to reimagine the role of the rep to better adapt to the new rules of engagement

Uncorking the compliance bottlenecks in digital

Andrew Stone, (Dec 17, 2020)

The sudden demand for digital content this year has created serious compliance bottlenecks that pharma is racing to overcome with new processes and technology

Maimah Karmo: Surviving, fighting, winning

Andrew Stone, (Nov 26, 2020)

The Tigerlily Foundation President and Founder is more hopeful than ever that she can help pharma give Black women the representation they deserve in trials and beyond

COVID-19: A data challenge and a catalyst for new insights

Andrew Stone, (Nov 24, 2020)

The healthcare ecosystem has demonstrated its ability to share data to uncover new insights this year but there is more to be done, says Nigel Hughes, scientific director at Epidemiology, Janssen R&D